Galapagos NV Advances Cell Therapy Business Divestment Review; Expects Decision By November 5, 2025
Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV ((Euronext &, NASDAQ:GLPG) and its Board of Directors today issued the following statement:On May 13, 2025, Galapagos announced that its Board of Directors